During the past decade, Clinical Hospital Center Zemun conducted 40 clinical trials. In the 10-year time frame, 40 clinical trials started and 26 clinical trials were completed, i.e. on average, 65% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 19 clinical trials were completed. i.e. 271.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Hospital Center Zemun" #1 sponsor was "Celgene" with 7 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Shire" with 5 trials sponsored, "Clinical Hospital Center Zemun" with 4 trials sponsored and "Takeda" with 4 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Hospital Center Zemun" #1 collaborator was "Gilead Sciences" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Charite University, Berlin, Germany" with 1 trials as a collaborator, "Clinical Center Kragujevac, Kragujevac, Serbia" with 1 trials as a collaborator and "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Hospital Center Zemun" are "Ulcerative Colitis" (11 trials), "Crohn's Disease" (10 trials), "Pulmonary Arterial Hypertension" (5 trials), "Coronary Artery Disease" (4 trials) and "Crohn Disease" (4 trials). Many other conditions were trialed in "Clinical Hospital Center Zemun" in a lesser frequency.

Most popular intervention types in "Clinical Hospital Center Zemun" are "Drug" (55 trials), "Biological" (3 trials), "Device" (3 trials), "Other" (3 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (24 trials), "Ozanimod" (3 trials), "RPC1063" (3 trials), "Adalimumab" (2 trials) and "Etrolizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Hospital Center Zemun" are 63 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Hospital Center Zemun". undefined are not yet recruiting, 5 are recruiting, 8 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 36 completed trials in Clinical Hospital Center Zemun, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Hospital Center Zemun, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 38 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 5 trials that are defined as “Not Applicable".

Clinical Hospital Center Zemun has several departments that took part in Clinical trials: "Clinical Hospital Center Zvezdara Clinic of Internal Diseases" - 5 trials, "Municipal Institute for Lung Diseases and Tuberculosis" - 4 trials, "Clinical Center Of Serbia, Clinic of Urology" - 29 trials